Whitney Laboratory

[Science Translational Medicine @ScienceTM]

The experimental antiviral #galidesivir inhibits two isolates of #Zika virus and safely reduces the severity of infections in macaques, demonstrates new research from @BIDMChealth. #GlobalHealth #antiviral https://t.co/deR9gAacpW

[Whitney Laboratory @_WhitneyLab_]

please take a look at our most recent study on the broad-spectrum antiviral galidesivir:

https://t.co/dFpsx1D28D

[Whitney Laboratory @_WhitneyLab_]

Some additional findings on early antiretroviral treatment from the Whitney Laboratory:
https://t.co/U5fNROhSZV😃

[Whitney Laboratory @_WhitneyLab_]

Please check out some recent findings on HIV-1 and CD32 from our Laboratory.😀
"Evidence that CD32a does not mark the HIV-1 latent reservoir". The paper is available online here:
https://t.co/apTCDWx8n7

[defeatHIV @defeatHIV]

Mike Elliott, Vice President of Medical Affairs at @GileadSciences chats about their new new #hivcure candidate GS 9620 and the company's efforts to cure #HIV https://t.co/MTWBkYhSth

[Whitney Laboratory @_WhitneyLab_]

TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy https://t.co/IecoZuuFCG

[Whitney Laboratory @_WhitneyLab_]

Our article has been recommended on @F1000Prime https://t.co/5K02EsVD82

[Whitney Laboratory @_WhitneyLab_]

Recent work from our Laboratory.😀 https://t.co/UPySe0hEd8

[Science Translational Medicine @ScienceTM]

Toll-like receptor 7-boosting agents reduce the #SIV viral reservoir in monkeys @BIDMChealth https://t.co/OXDExbqOHN